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Understanding how engineered nanomaterials affect immune responses of living organisms requires a
strong collaborative effort between immunologists, toxicologists, ecologists, physiologists, inorganic
chemists, nanomaterial scientists and experts in law and risk management. This perspective aims to provide
a new viewpoint on the interaction between engineered nanomaterials and the immune defensive systems
across living species, gained within the EU Horizon 2020 project PANDORA. We consider the effects of
nanoparticle exposure on immune functions in plants, marine and terrestrial invertebrates and their relation
to the current state of knowledge for vertebrates (in particular humans). These studies can shed light on
the broader perspective of defensive and homeostatic mechanisms (immunity, inflammation, stress
responses, microbiota, stem cell differentiation) suggesting ways to: i) perform a comparative analysis of
the nanoparticle impact on immunity across model organisms; ii) inspire best practices in experimental
methodologies for nanosafety/nanotoxicity studies; iii) regroup and harmonise fragmented research
activities; iv) improve knowledge transfer strategies and nano-security; v) propose innovative tools and
realistic solutions, thereby helping in identifying future research needs and tackling their challenges.
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Environmental significance
This perspective is based on the experience gained within a collaborative work that compared the immune reaction to NPs in plants, invertebrates and
vertebrates. Each species uses a shared number of core defensive mechanisms upon exposure to NPs (recognition, uptake, gene regulation, production of
defensive molecules), and then adapts them and adds others to its own specific requirements. In general, an immune reaction to NPs is not detrimental
for the organism and resolves rapidly with NP elimination, while in few cases it can produce damage or have beneficial effects. Each species has its own
peculiarities, but the commonality of their basic defensive mechanisms becomes a valuable tool for NP-related environmental health risk assessment and
management.
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1. Nanoparticles: health, immunity
and environment
Assessing the safety of nanoparticles (NPs) has been
identified as a priority, because of the potential challenges
that this kind of agent could pose to the environmental and
human health. Over the past decades, there has been a
significant increase in the number and production volumes
of nano-enabled products coming to market. As the diversity
of NP production and use has increased, the need to identify,
measure and manage the associated hazards and risk has
been recognised. Despite significant progress, many gaps still
remain in our knowledge of how NPs interact with
organisms. Gaps in understanding include details of the
mechanistic pathways of NP toxicity at the cellular level (e.g.,
interactions with biological macromolecules, effects of signal
transduction mechanisms, cellular stress and cell function),
at the level of tissues/organs (e.g., blood vessels, immune
cells), individual organisms and population/community (e.g.,
resource allocation species sensitivity, ecosystem process
impacts). Such information would significantly improve the
basis for NP risk assessment and management.
One of the major shortcomings in our understanding of
the effects of NPs relates to the impact of NP exposure on the
immune system. The conserved nature of many immune
mechanisms suggests that comparative studies on the
immune responses of organisms covering different phyla and
hierarchical levels of organization can together provide a
knowledge base for understanding the mechanisms and
consequences of NP exposure on human and environmental
health. Key topics for comparative nano-immunosafety
studies include: i) the identification of species differences
and/or species similarities in the immunological mechanisms
triggered by NPs; ii) the extrapolation of predictive markers
of risk vs. safety by a cross-species comparison of innate
immune defence capacity; iii) the design of predictive in vitro
assays, in the practical and vigilant application of the 3R
principle, to measure the nano-immunological risk to the
environment and human health, for industrial and
environmental nanosafety testing application.
The full functioning of innate immunity is of central
importance for the survival and fitness of organisms, because
of the critical role of immunity in preserving tissue and
cellular homeostasis. The particulate nature of NPs dictates a
preferential interaction with those cells in the immune
system that are deputed to recognition and elimination of
foreign particulate matters.1 NPs can interact with the
immune system in a number of ways, which in the majority
of cases end in a defensive reaction that resolves with the
elimination of the particles and the re-establishment of
homeostasis.2,3 In some instances, however, reaction to NPs
may trigger an anomalous immune response. This can be
evident as a quantitatively exaggerated or insufficient
response (immune hyperreactivity or immunodeficient
response) and also as a response sustained over extended
timescales, beyond those taking place under normal
physiological conditions, again implying hyperreactivity.4
While such reactions may be at the basis of inflammatory
and other pathologies, on the other hand the NP capability to
activate, regulate or modulate immune responses is of great
interest, because of potential developments into treatment
strategies for numerous disorders, such as autoimmune and
inflammatory diseases, and cancer.5 Thus, assessing the
impact of NPs on the immune system not only is an issue of
common immuno-nanosafety (reactive mechanisms shared
among all organisms), but it can also provide an improved
understanding of the impact of NP exposure on the nano-
immune interaction that can be exploited for targeted
immunomodulation, disease management and crop
protection.
By studying and comparing humans, plants and
invertebrates, we can learn much about the general and specific
mechanisms of the NP effects on immunity. The interactions of
NPs with cells and molecules of the innate immune system
represents the best ground for understanding the common
mechanisms of immune defence. Innate immunity includes
natural barriers at the organism–environment interface that
limit internal exposure to pathogens, and an array of different
cellular, molecular and chemical effector and regulatory players
participating to the defensive responses. The full operational
capacity of innate immunity is a major determinant in the
survival and fitness of all organisms. Therefore, the
immunosafety of engineered NPs is a key element of
environmental nanosafety. The fact that living species have been
consistently exposed to potential pathogens and other threats
through their extended evolutionary history has directed the
evolution of innate immune protective signalling pathways and
mechanisms towards diversification (mainly dependent on
species and environmental characteristics) of specialized
immune-related molecules, which mediate cellular responses.6
Ecological immunology attempts to explain variability in
immune defence, and, in turn, shows that the optimal immune
response changes with environmental changes, establishing an
evolutionary ecology framework around immunity.7 Since the
appropriate functioning of the immune system is important for
maintaining individual health, an agent that compromises its
function can have implications for survival, reproduction and,
hence, population fitness. Here we discuss the potential of NPs
to act as agents affecting the immune status in different
environmentally relevant species, with a focus on the emerging
experimental models launched by the EU Commission H2020
project PANDORA (probing safety of nano-objects by defining
immune responses of environmental organisms).8
2. Nanosafety and nanotoxicity:
considerations from an
immunological perspective
Living organisms have developed highly efficient defence
biological barriers to block foreign species/substances and
prevent damage to the organism's tissues. In the context of
Environmental Science: Nano Perspective
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understanding the biological effects of NPs, an important
consideration is the extent by which particles may enter the
organism, distribute across tissues, pass into cells and
interact with organelles, DNA and other macromolecules. The
external body surfaces (e.g., skin, lungs and intestine) are
where NPs first interact with a living organism. Their active
defensive barrier functions determine the extent of NP–tissue
interaction and internal distribution. Plants and
invertebrates possess additional types of physical/biological
barriers (e.g., exoskeleton, peritrophic membrane) that can
further prevent the NP entry.9 These barriers largely rely on
cells working as a basic functional unit (e.g., epithelium),
which prevent NPs to go deeper into tissues.10 If poor tissue
permeability is a significant barrier to particle entry, NPs may
still enter tissues in a number of ways.11 The physico-
chemical properties of NPs (e.g., size, surface charge and
shape), their bio-modification during translocation in the
body, and the physiological and pathological conditions of
the animal, all influence the NP capability of interact with
the barriers. On the other hand, there is no available
evidence that the effects on barriers depend on the NP
concentration. As an example of the complexity of NP–barrier
interaction, NP translocation through the intestinal barrier is
a multistep process that involves NP diffusion through the
mucus layer, contact with enterocytes and/or M cells, uptake
via endocytosis, and translocation to the subepithelial tissue
via transcytosis.12 Some invertebrates (e.g., mussels,
earthworms, arthropods) have fine food sorting systems, and
food particles are taken and digested intracellularly by cells
in the gut lumen.13,14 NPs may follow the same route as the
food particles. In some coelomates (e.g., mussels,
echinoderms) free circulating immune cells are present in all
coelomic spaces, including the perivisceral coelomic cavities
and the open water-vascular system, and in the major organs
and tissues. In the open circulatory system, the NPs are likely
to be entrapped by phagocytic cells and to be moved quickly
through the body fluids. Thus, some types of barriers may
likely fail to prevent the NP entry. Although the anatomical,
physiological and biochemical barriers vary widely from one
species to another, all organisms are organized into similar
levels of anatomical structures (sub-cellular entity, cell,
tissue, organ, apparatus, organism). In the Fig. 1 are shown
the anatomical maps of some invertebrates, in which the
location of immune cells is shown, relative to the main
barriers.
Changes in cell/tissue/organ functions following NP
exposure may indirectly affect immune functions. A relevant
example is the effect of biocidal NPs on the structure and/or
function of the gut microbiota.15 The resident microbiota
plays a central role in the stimulation, training, and function
of the host immune system. In healthy physiological
conditions, the immune system and microbiota cooperate in
inducing protective responses to foreign substances and in
maintaining regulatory pathways.16 All organisms initiate
immune reactions to maintain metabolic homeostasis and
self-integrity after suffering from stress, injury or invaders.
They require mechanisms to recognize damage, to
discriminate between the molecular signatures of invading
pathogens (“non-self” molecules) and cellular constituents
that generally pose no health risk (“self” molecules), and to
discriminate “self” from “damaged self”.17 An interesting
question is whether it could be possible to predict innate
defence responses against NPs based on how the immune
system manages pathogens. NPs may (or may not) set the
immune system in motion, communicate with cells,
receptors and proteins, trigger signalling cascades, and
generate unpredictable immune responses (activation or
suppression) as well as other harmful outcomes,18 depending
on their physico-chemical characteristics, especially their
surface properties.19 In the case of nanomedical applications,
it may be attractive to design NPs able to engage with the
immune system in a specific manner, e.g.,
immunostimulation or immunosuppression, depending on
the intended use. This has encouraged the development of
NP and cell-based hybrid systems that cannot be detected/
eliminated by the immune system, making them highly
Fig. 1 Anatomical maps of some invertebrates, showing the location of immune cells relative to organs and barriers. A) Mussel; B) echinoderm; C)
arthropod.
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biocompatible and physiologically integrable within tissues
in humans.11 For example, nanoporous silicon NPs coated
with cellular membranes purified from leukocytes are able to
elude the immune system, avoiding opsonization and
phagocytosis, and to transmigrate across the endothelial
barrier to enter a tissue.20
Notably, some NPs may selectively accumulate in organs
with high adsorptive, filtering and detoxification capacity
(e.g., spleen, liver, kidney, intestine and lung), engulfed by
the mononuclear phagocytic system (MPS) that includes both
resident macrophages and circulating blood monocytes.21
Phagocytic cells are responsible of several important
processes, including clearance (engulfment/elimination of
putative threats), biodistribution (selective localisation in
organs and tissues) and balance between tolerance and
toxicity (e.g., between production of reactive oxygen species
–ROS– and antioxidant response). Each organ can count on
the availability of an exclusive equipment of cells that
coordinate and perform local innate immune reactions. The
cells responsible of innate immune activities include both
“professional” immune cells (such as mononuclear and
polymorphonuclear phagocytes, mast cells and innate
lymphoid cells) and non-professional defence cells, such as
endothelial cells, epithelial cells, and fibroblasts.22
Experimental methodologies for nanosafety/nanotoxicity
studies must allow us to capture the relevant details of a
complex nano-immune interaction. While in vitro models
facilitate the analysis of particle effects on isolated single
cells and tissues, in vivo models allow for a clearer evaluation
of the NP effects in whole organs or in the entire organism.
While exposure time, route, and NP concentration help in
determining the modes of interaction between NPs and the
immune system (or any other system they come in contact
with), there is a parameter that is of major importance in any
kind of nano-bio interaction, i.e., the changes particles
experience when coming in contact with biological fluids.
Mimicking such interactions in the laboratory is always
challenging because of the complexity and multiplicity of
interactions taking place in real life environments. For
instance, the presence of natural organic matter (including
toxins) may play a role in the NP partition, which is difficult
to control but that should be considered, as they are part of a
natural environment. This is a critical point in the context of
ecotoxicological assays and how and to which purpose we
want to use them. Thus, given the advantages of the in vivo
and vitro/ex vivo approaches in providing nanosafety
information, future studies should aim to improving the
exposure conditions of the ecotoxicological assays in order to
better mimicking complex environments and provide realistic
and valid nanosafety data.
Aggregation/agglomeration influences the fate of the NPs
in the environment, particularly in aqueous environments.
NP colloidal stability is influenced by the solution ionic
strength, organic matter composition, pH and solvent
composition. In some conditions NPs can agglomerate, and
return in colloidal solution when the conditions change,
while in some cases NPs can aggregate, forming irreversible
larger clusters. Heteroaggregation/agglomeration, in which
NPs are admixed with other environmental molecules/
particles, is likely the most common form in which NPs are
present in the environment and come in contact with living
organisms. Such complexes can also associate with other
environmental biological and non-biological contaminants,
such as bacterial toxins (e.g. Gram-negative endotoxin) and
chemicals.23 Since these complexes are the real-life forms in
which NPs come in contact with living organisms, the
future ecotoxicological assays should consider using
complex environmental matrices to adequately reflect the
exposure conditions in real life. Although nude particles
can rapidly aggregate/agglomerate in a fluid, coated
particles acquire chemical functions of the coat that modify
the particle behaviour, for example by reducing the
formation of aggregates/agglomerates. Within biological
fluids (blood, haemolymph, coelomic fluid, mucus, etc.),
which are rich in biomacromolecules (e.g., lipids, sugars,
nucleic acids, and particularly proteins), NPs readily adsorb
on their surface various organic molecules that form a
complex biomolecular corona and lead to an increase in the
NP hydrodynamic range.24 Large aggregates/agglomerates
are transported in vesicles via different mechanisms of
endocytosis/exocytosis (based on the size, shape and surface
characteristics, and the cell internalization machinery).25
For example, NPs of <200 nm can be internalized via
clathrin-coated pits by non-phagocytic cells, whereas at
increasing size a shift towards caveolae-mediated
internalization become predominant.26 NPs can also enter
cells by a passive uptake, which can or not disturb the
membrane depending the size of the NPs. Small NPs have a
higher probability to be internalized by passive uptake than
large ones.25
The bio-corona composition may vary among different
NPs and upon contact with different biological fluids that
contain different mixtures of biomolecules. The bio-corona
evolves with time, with a progressive loss of molecules of
lower avidity (soft corona) and the establishment of a hard
corona of strongly interacting biomolecules. The structure
of this macromolecular coating is most likely a key factor in
making the NPs “visible” to cells for uptake, contributing to
clearance from circulation and possibly reducing their
interactions with other cells and tissues.27 On the other
hand, functionalizing particles with some capping agents
(e.g., polyethylene glycol) reduces accumulation of proteins
on the NP surface, making them functionally “invisible” to
the immune system in humans.28,29 The majority of the bio-
corona studies have been performed in vitro, and have
contributed to unravel the role of the bio-corona in the
immune recognition of NPs. Conversely, the in vivo
approach is important for a better understanding of the
mechanisms of particle clearance vs. toxicity, which would
be greatly improved by examining the differences in
clearance kinetics and type of toxic effect across living
species.
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Vertebrates and invertebrates display common immune
mechanisms but they have also developed divergent immune
tools for attaining challenge-specific protection. As an
example, whereas vertebrates use somatic rearrangement of
immune receptors and immunoglobulins, invertebrates
privilege alternative splicing of pattern-recognition genes.30
Whereas vertebrates have developed an array of different cell
types as effectors of innate immune responses (e.g.,
monocytes, macrophages, mast cells, neutrophils, basophils,
eosinophils, NK cells, ILC, epithelial cells, fibroblasts),
invertebrates use a limited range of multifunctional cells.
Plants do not have specialised immune cells, with all cells
being able of innate immune reactivity and with systemically
spreading signals emanating from injured sites.31
The innate immune system also exhibits adaptive traits, a
feature that has been termed “innate immune memory” (or
“trained immunity” in vertebrates).32 The innate immune
memory is the ability of the immune system to record and
recall information of previously met pathogens to activate a
faster and more efficient protective response upon re-
exposure to the same or different pathogens/stressful
agents.33 The phenomenon is well known in plants and
invertebrates, which also show some degree of specificity,34,35
and has been also observed in vertebrates (in particular
mouse and man), in which however the memory is as non-
specific as innate immunity itself.32 How NPs may induce/
alter innate memory is an open issue that requires special
attention, as alteration of immune memory can modify the
capability of an organism to adapt to its environment. NPs
can modulate stimulus-induced memory in human
monocytes, mostly by shifting the memory response towards
tolerance.36 Innate memory in plants is known as systemic
acquired resistance (SAR), which leads to the activation of a
better protective response (e.g., increase in the levels of
pattern-recognition receptors, accumulation of dormant
signalling enzymes, alterations in chromatin state) not only
in the tissue re-exposed to the same or similar insult but also
in an unexposed tissue.37 If found able to induce an
epigenetic and metabolic reprogramming of immune
responses, as they are able to promote root growth (B.
Kemmerling, unpublished results), NPs would support the
design of new agriculture strategies able to reduce yield
losses, thereby allowing for reduction of conventional
pesticides. Invertebrates show a high degree of memory in
their immune responses, including recall immunity to
infections, natural transplantation immunity, and individual/
trans-generational immunological priming.34 How NPs can
affect the establishment of innate memory in invertebrates is
however still largely unknown. The only available results
describing nanoplastics-induced innate memory and some
underlying molecular and cellular mechanisms come from
mussels.38 Upon a primary exposure to amino-modified
nanopolystyrene, Mytilus haemocytes respond with changes
in some immunological parameters (e.g., lysozyme release in
Fig. 2 Impact of NPs on the microbiota–immune axis in vivo: differences across environmental organisms.
Environmental Science: NanoPerspective
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the haemolymph, lysosomal acidification, membrane
destabilization), whereas a second exposure induces an
immunological memory by shifting the immune parameters
towards a tolerant condition (recovery).
An important issue that should be considered when
examining the interaction between NPs and immunity is the
role of microbiota. This is particularly important for NPs that
are ingested (as in the case of most aquatic and terrestrial/
earth-dwelling invertebrates and vertebrates) but also for NPs
to which organisms are exposed through the skin or
inhalation, because symbiotic and commensal microbiota
populate the gut and all the barrier surfaces or
environmental organisms and it is well known that
microbiota profoundly influence and shape immunity at the
barrier level.39 However, little is currently known on how the
interaction between NPs and commensal microbes can
impact on immune responses, in particular in the long term
(Fig. 2).
Recent data show that TiO2NPs impact the immune
system of mussels and induce a shift in the microbiota
composition of the haemolymph40 upon exposure in vivo,
while CuONPs cause a shift in the earthworm gut microbiota
despite the absence of an evident immune reaction.41 The
only available data on impact of NPs on the human
microbiota–immune axis come from in vitro studies, which
underlines an essential a lack of information on the realistic
impact of the NPs ingested via food in humans.39 Whether
chronic dietary exposure to NPs may be viewed as a risk
factor that facilitates disease development remains an open
issue.
In the next section, we will provide an overview of the
environmentally relevant organisms and approaches used,
within the framework of the EU PANDORA project, to study
nano-immune interactions and identify their common vs.
divergent mechanisms.
3. Nanotoxicological evaluations:
in vivo and in vitro models for
studying nano-immune interactions
The 3R principle of reducing, refining, and replacing animal
experimentation42 has led to new approaches to in vivo
experimental studies, with an increasing use of invertebrate
animal models. Studying the interactions between NPs and
the immune system across animal phyla allows us to identify
both conserved mechanisms and species-specific defence
solutions. Plants differ from animals because they are
autotrophs, but nevertheless show conserved/converging
defensive mechanisms that could greatly help in clarifying
the mechanisms of defence and repair in animal species.
Some invertebrate organisms, by virtue of being easy to
handle, breed and maintain, are becoming popular
experimental models, in particular in ecotoxicological
research and in comparative immunology. However, the
different demands of the two disciplines have brought
scientists to select different model species for their studies.
As a consequence, our current knowledge of the immune
functions of species used in ecotoxicology is faulty, and
likewise we have an incomplete knowledge of the
ecotoxicological aspects in species whose immune functions
are well known.
In this section, we report and discuss recent studies
aiming at integrating nanotoxicological evaluations with
assessment of immune-related effects in plant, human and
invertebrate animal models, in vivo and in vitro (Fig. 3). We
will examine the similarities and differences in the defensive
responses of each organism upon exposure to NPs.
Comparison will contribute to increasing our knowledge of
the commonalities in the immune reaction to NPs, and allow
us to identify pathways and biomarkers of nano-risk that are
shared across species. Notably, several features must be
considered in order to correctly evaluate the NP interaction
with the immune defences in the selected experimental
models: experimental conditions (in vivo, in vitro/ex vivo);
environmental factors; basal immunological state;
immunological memory.
3.1 Plants
Plants are in constant contact with the rising number of NPs
released into the environment. Given the importance of
plants in determining ecosystem functions such as stability
and resistance,43,44 studying plant-NP interactions is an
important element to assess the risk of NPs for the
environment.
Plants have a well understood immune system able to
detect and react to danger, and are easily accessible to
genetic and biochemical analyses and therefore provide a
valuable tool for NP-related risk assessment.45 Plant
immunity is an exceptional example of sensing capability
based on networks of immune receptors that act as sensors
Fig. 3 Overview of the experimental models for investigating the
interactions of nanomaterials with the immune system used within the
EU Commission H2020 project PANDORA: from the plants to humans.
Environmental Science: Nano Perspective
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of invading pathogens.46 Receptors evolve rapidly to keep up
with the pathogens' variability, and interact with each other
creating systemic signals emanating from infection sites that
induce an effective immune response. The task of mounting
an immune reaction is not dependent on specialized
immune cells, but each plant cell is able to react against
invaders. The plant immune system is organised in three
layers, the pathogen-associated molecular patterns (PAMP)-
triggered immunity (PTI) (preliminary defence), the effector
triggered immunity (ETI) (secondary defence), and the
exosome-mediated cross-kingdom RNA interference (CKRI)
system (additional defence).47 Resistance against a non-
adapted pathogen involves the rapid production of cell wall
appositions (physical barriers), and inducible-specialized
metabolites at the infection sites via PTI and ETI
signalling.48,49
The growth and metabolic functions in response to NPs
vary among plants.50 Reports reveal contradictory effects of
NPs depending on the experimental conditions (field or lab
studies), medium of plant growth, duration of exposure and
species.51 For example, TiO2NPs improve light absorption
efficiency and promote the activity of Rubisco activase,
accelerating growth in spinach;52 whereas they reduce the
photosynthetic rate thereby decelerating growth in Ulmus
elongata.53 Arabidopsis thaliana leaf cells exposed to large
particles of single-walled carbon nanotubes form
endocytosis-like structures in the plasma membrane, whereas
the same particles fail to penetrate the cell walls in other
plants.54 Notably, the interaction of plant cells with NPs leads
to the modulation of plant gene expression and related
biological pathways, which in turn influence plant growth
and development.55 For example, exposure of A. thaliana to
gold NPs induces the expression of a few key regulatory
molecules and microRNAs (miRs) thereby stimulating seed
germination, growth, and antioxidant metabolic activity.56 A.
thaliana is a small model plant with a short life cycle, which
allows for easy manipulation and study. The observations
made in this species for studying NP uptake and metabolism
encourage more relevant and significant research in this
field, due to commonalities between Arabidopsis and edible
plants. Well controlled and field studies will allow us to get
an overview about the potential of plants to recognize and
react to NPs, keeping in mind that NPs bear also the
potential to improve plant yield and health and reduce crop
loss by specific, localized and efficient application of nano-
fertilizers, pesticides or immunostimulating agents.51
3.2 Protostomes
Earthworms. Earthworms (annelid subgroup) are the most
abundant invertebrates present in soils worldwide. The
permeable skin and the digestive tract place earthworms in
constant contact with the soil particles, which may contain
an unknown number of pathogens and pollutants. To face
this challenge, earthworms developed a variety of defence
mechanisms efficiently recognizing and responding to “non-
self” substances, including anatomical and chemical
protective barriers (e.g., skin, mucopolysaccharides), cellular
responses (phagocytosis, nodule formation and
encapsulation, blood coagulation and wound repair) and
humoral responses (antibacterial proteins, lysozyme-like
proteins, proteases, cytolytic proteins, agglutinins,
haemolysins, opsonins, lectin-like and pattern recognition
molecules).57 Direct contact between microorganisms and the
earthworm immune components occurs at the mucosal
surfaces of two body cavities, the coelomic cavity and the
digestive tract (gut). Both cavities are in permanent contact
with the soil microorganisms. Different defensive strategies
are in place in these two cavities. The coelomic cavity
contains free circulating cells (effector immunocytes called
coelomocytes) and indigenous microflora (bacteria,
protozoans and fungi) that work together to prevent
colonization and invasion by pathogens or other
dangers.58–60 Coelomocytes produce a broad spectrum of
antimicrobial molecules and release them into the coelomic
fluid to control the levels of the indigenous microflora.61 On
the other hand, the gut is in permanent contact with the
indigenous microflora and other exogenous bacteria that are
ingested with the soil particles and that may have beneficial
effects on the integrity and health of the gut epithelium.62
Notably, the human gut microbiota is known to play a key
role in protecting against pathogens and in preserving
immune and metabolic homeostasis.63
The mechanisms of interaction of NPs interact with
different components of the earthworm immune system are
still not well defined. There are data showing that AgNPs,
both in vivo and in vitro on Eisenia fetida coelomocytes, can
transiently affect the expression of a number of immune-
related genes, such as those involved in oxidative stress (CAT,
SOD), energy metabolism (aspartate aminotransferase,
glucose-6-phosphate isomerise, phosphoglucomutase) and
immune response (lysozyme, MyD88, PKC, MEKK1).64,65 The
intracellular signalling pathway involved in the AgNP-
induced modulation of earthworm immunity apparently
involve the myeloid differentiation factor 88 (MyD88)
(encoding a central adaptor protein of toll-like receptors),
and the mitogen activated protein kinase (MAPK) cascades.65
This upstream signalling cascade induces activation of
nuclear factor (NF)-κB, resulting in transcription of genes
encoding inflammatory cytokines in humans.66 Cytokine
production is necessary for defence, but it can also induce to
tissue damage by inducing the generation of ROS, enzymes
and other toxic defensive molecules.67 These findings
underline the presence of conserved innate immune
activation mechanisms and pathways between earthworm
and human immunity. In agreement, the 1H NMR-based
metabolomic analysis of Eisenia fetida earthworms exposed to
TiO2NPs in soil showed significant changes in the metabolic
profile consistent with oxidative stress as the main
mechanism of immune-related inflammation/toxicity.68 Upon
exposure to another type of particle, CuO2NPs, in soil, the
earthworm Metaphire posthuma showed an immune
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metabolic impairment in term of nitric oxide generation,
superoxide dismutase, phenoloxidase, catalase and alkaline
phosphatase activity.69
Since earthworms ingest soil and their associate
microbiota, the NP effects on the soil microbial
communities70–72 will affect the composition of the
microbiota in the earthworm gut. This is particularly
important, in terms of effects on immune functions, because
the interaction between immunity and microbiota at the gut
level defines the defensive capacity of an organism (from
earthworms to human beings), and any variation of
microbiota can affect immune competence. Unfortunately,
little is known on how NPs might interact with earthworms'
bacterial communities and even less on how this might affect
their immunity. Earthworms capture NPs from contaminated
soil using mucus glycoproteins/glycans of gut/microbial
origin.73 Exposing the oligochaete Enchytraeus crypticus to 50–
100 nm plastic particles caused a significant shift in the gut
microbiota, including a significant decrease in the relative
abundance of the families Rhizobiaceae, Xanthobacteraceae
and Isosphaeraceae,74 but how these changes may affect
immunity is unknown. The earthworm Eisenia fetida can
survive in soil containing high ZnONP concentrations, and
accumulate zinc ions in the body. ZnONPs enhance the
activity of cellulolytic bacteria (Bacillus and Pseudomonas sp.)
in the gut, contributing to bioconversion (digestion) of
lignocellulosic waste.75 The metagenomic analysis of Eisenia
fetida earthworms exposed to ZnNPs in soil shows a decrease
in biodiversity of the gut microbiota, mainly due to a
significant decrease in the relative abundance of the phylum
Firmicutes.76 Reduction in the abundance of these bacteria
correlates with inflammatory/autoimmune diseases in
mammals.77 Although there is no strong evidence that this
type of correlation occurs in earthworms, we can speculate
that NPs impacting the gut microbiota can consequently
affect the earthworm immunity upon in vivo exposure. This is
based on the consideration that amoebocytes, the most active
immune cells in the earthworm, are involved in a broad
range of defensive functions in the gut78 reflecting the
abundance of immune cells in the gut of vertebrates.
However, recent data show that in vivo exposure to CuONPs
can cause significant changes in the gut microbiota and
microbiome of earthworms, but it does not affect the
expression of immune-related genes (e.g., coelomic cytolytic
factor, lysenin/fetidin, lysozyme) and resistance/susceptibility
to a bacterial infection.41 Future studies of gene expression
based on a greater time resolution of immune responses may
aid the understanding of whether and how NPs could impact
on the dialogue between gut commensals and immune cells
in the earthworms.
Mussels. Mussels (mollusc subgroup) edible bivalves
widespread in estuarine and coastal area, have long been
used as a model to evaluate the biological impact of
contaminants.79 As suspension-feeding invertebrates, they
are particularly prone to NP exposure, due to their extremely
well-developed systems for the uptake of nano- and
microscale particles.80,81 Mussels are an excellent model for
understanding the interaction between NPs and innate
immunity, because their biochemical and physiological
responses to a variety of environmental stressors and
pathogens are well known,79,82 they are easy to handle
experimentally, including the non-invasive sampling of
immune cells (haemocytes) and blood (haemolymph).
However, long-term cultures of haemocytes and in vitro
studies are still not feasible. Upon in vivo exposure to
environmentally relevant concentrations of different NPs, it
is important to note that mussels show little particle
accumulation and toxicity, but that nevertheless immune
functions can be affected.82
The interaction of NPs with the mussel biological fluids, in
particular the haemolymph, allowed for the identification of
specific proteins forming a stable biocorona on the NP surface,
and to assess the features of the haemocyte interaction with
the biocorona-coated NPs. Depending on the NPs and its bio-
corona, this interaction can lead to distinct responses
(recognition, internalization, activation/inhibition of immune
responses), and therefore results in distinct
immunomodulatory pathways.83 These findings underlie the
strong similarities with the features of the nano-immune
interactions in mammalian cells, suggesting that this model
could be suitable for investigating the mechanistic basis and
the biological outcomes of such interactions in conditions that
reflect those in both mammals and environmental organisms.
Notably, recent data showed that the immunomodulatory
effects of different types of NPs are linked with shifts in the
microbiota composition of the haemolymph, underlying a
relationship between innate immunity and host microbiota in
mussels, as it occurs in mammals.40
Terrestrial isopods. Terrestrial isopods (arthropod
subgroup) comprise a group of crustaceans that have
acquired a terrestrial lifestyle. They are keystone species in
terrestrial ecosystems, contributing to the decomposition of
plant detritus and regulating the microbial food mesh.84 The
terrestrial isopod Porcellio scaber is increasingly used as
model organism to evaluate the toxicity of chemicals and the
bioaccumulation of pollutants in soil, including NPs. The
main cellular effectors of P. scaber immune system are the
haemocytes, free moving sentinel cells capable of
phagocytosing, encapsulating and sequestering pathogens. As
mammalian macrophages, haemocytes are also involved in
carbohydrate metabolism and in transporting and storing
amino acids and proteins. Chronic exposure to NPs in food
(AgNPs, CeO2NPs) did not result in immune activation,
although it caused changes in proteins, lipids, nucleic acids
and carbohydrates at the tissue level.85,86 It is likely that a
direct contact between NPs and haemocytes cannot take
place, because the mineralised cuticle that surrounds most of
the gut epithelium is believed to reduce translocation and
uptake of NPs from the gut into the haemocoel. This is an
important notion, which must be considered also in human
exposure: the physical/mechanical barriers at the body
surfaces block the vast majority of external particles from
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entering the body. On the other hand (and this is again true
also in mammals), NPs may affect P. scaber immunity
indirectly, for example by impacting the gut microbiota.87
3.3 Deuterostomes
Echinoderms. Echinoderms (ambulacraria subgroup)
represent the most developed marine invertebrates and the
bridge leading to the primitive chordates (urochordates and
cephalochordates). Echinoderms (crinoids, ophiuroids,
asteroids, holothuroids, echinoids) share several common
characteristics, such as a penta-radial symmetry and a highly
specialized water-based vascular system open to the outside.
This last characteristic explains why these animals are
particularly sensitive to rapid water chemistry variations (e.g.,
ion content) and why they have developed a complex, prompt
and sophisticated immune system.74 Environmental pressure
favoured phenotypic plasticity in echinoderms, conferring an
individual ability to generate multiple phenotypic states and
activities (e.g., metabolism).88 The survey of the sea urchin
genome has disclosed strong similarities between sea urchin
and human innate immune-related genes, and also provides
clues of alternative adaptive or anticipatory immune functions
that are shared with humans.89 For these reasons, the sea
urchin can be considered an excellent proxy for human model
for investigating the nano-immune interaction in vivo90–91 and,
more recently, also in vitro. The establishment of long-term sea
urchin phagocyte cultures that maintain the physiological
functions of fresh cells will allow for a deeper understanding of
the mechanisms of immune activation by NPs.92
Current studies of the interaction of NPs with the immune
system of the sea urchin Paracentrotus lividus show that, as in
humans, a number of sea urchin extracellular proteins
(glycoproteins, cytoskeletal proteins) form a biocorona on the
particle surface in vitro.93 The protein-coated TiO2NPs are
internalised more efficiently, transiently down-regulating the
expression of genes encoding for proteins involved in
immune response (NF-κB, FGFR2, JUN, p38MAPK), and
increasing a few antioxidant metabolic pathways (pentose
phosphate, cysteine–methionine, glycine–serine).2 Conversely,
studies on sea urchin phagocytes exposed to PVP-AuNPs
in vitro underline the transient involvement of the TLR4/ERK
signalling pathway based on increased protein levels.94 The
notion that these NPs do not cause a pathological immune
response and associated irreversible damage in sea urchins
may prompt us to consider them immunologically safe also
for other environmental species and human beings, given the
commonality of involved defensive mechanisms.
Thus, the combined use of in vivo and in vitro
investigations, its proximity to mammalian reactivity as well
as the similar features with invertebrate immune responses,
make the sea urchin a valuable model for the study of the
nano-immune interactions across evolution.
Representative images of the invertebrate models
described in this section and their immune cells are shown
in the Fig. 4.
Humans. The study of nano-immune interactions in humans
(Homo sapiens, chordate subgroup) has two main directions, the
NP immunosafety, when NPs are present as environmental
contaminants or when used as nanomedicines, and their
potential use for medical modulation of immune responses.
Most human in vitro models for assessing NP immune effects
use human cancer cell lines or immortalized cell lines, which
have the advantage of easy handling and high reproducibility.
However, as these cells lines mostly derive from cancer cells,
they have physiological and metabolic features that are
significantly different from those of normal primary immune
cells, and therefore they may not be predictive for human
Fig. 4 From the earthworm to the sea urchin: invertebrate models for the in vivo and in vitro studies of nano-immune interactions. A) The earthworm
Eisenia andrei. B) SEM image of a free circulating E. andrei coelomocyte. C) The mussel Mytilus galloprovincialis. D) SEM image of a free circulating M.
galloprovincialis haemocyte. E) The terrestrial isopod Porcellio scaber. F) SEM image of a P. scaber macrophage resident in the hepatopancreas; G) A
violet adult Paracentrotus lividus collected from the Mediterranean Sea. H) SEM image of P. lividus phagocytes cultured for 24 h.
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responses.95 Thus, the use of primary immune cells from
healthy tissue sources may provide much more reliable and
representative responses on the nano-immune interactions.96 In
particular, leucocytes from peripheral blood from healthy
donors are readily available and include all the major types of
professional immune cells, including the main innate cell types,
i.e., the mononuclear phagocytes (monocytes, dendritic cells),
the polymorphonuclear phagocytes (neutrophils, eosinophils,
basophils) and innate lymphoid cells. Thus, among the huge
number of in vitro studies on human nano-immune
interactions, those performed on human primary immune cells
are to be considered the most reliable/realistic.
An efficient and predictive method that can be applied for
assessing the general impact of NPs on human blood is the
whole blood assay,97,98 in which an aliquot of anti-coagulated
blood is challenged with NPs. This assay encompasses NP
coating with serum proteins and interaction with all types of
circulating cells, without however allowing for the identification
of specific cell types affected by NPs. Since phagocytes are the
first defence cells that confront particulate matter, we can
consider as the best models of innate immunity those based on
monocytes isolated from blood of healthy donors (MAT,
monocytes activation test), and on macrophages and dendritic
cells differentiated in vitro from fresh monocytes.99 These
models allow us to observe not only the direct activation of
immune cells by NPs but also the capacity of NPs to interfere
with the physiological course of an inflammatory response4 or
with the induction of innate memory.36 The in vitro systems
based on human primary cells present the main disadvantage of
all in vitro systems, i.e., they do not reflect the complexity of an
in vivo system, and, in addition, they suffer of donor-to-donor
variations. Such variations are however sufficiently limited in
the case of innate immune responses, with a general
homogeneity of qualitative reaction and variability evident only
in quantitative terms.100 Conversely, in the case of innate
memory responses the variability is much higher, as also
observed in adaptive immune responses, as memory depends
on the individual history of exposure. This notion underlines
the need of using human primary cells in immunoassays for
assessing nano-risk, since they are more predictive evaluation of
the NPs effect in vivo. Also, it warrants a personalised evaluation
of the NP effects on immunity, as each individual subject may
react differently to an NP challenge.
In light of the notion that an unbalanced immune response
underlies many diseases including autoimmunity, inflammatory
diseases and inflammation-related cancers, the potential effects
of NPs on the human immune responses requires extensive
attention. To obtain a realistic overview on the effects of NPs on
human immune responses, it is necessary to examine both the
direct effects of NPs on innate immune effector cells (capacity to
induce an innate/inflammatory reaction that does not resolve
and become chronic) and their interference with an ongoing
defensive innate/inflammatory response (capacity to exacerbate
or inhibit a defensive response). In the latter context, the effects
of NPs on the development of innate memory could be of great
interest. NPs could be appropriately designed for modulating
innate memory to treat two opposing conditions, i.e., diseases
where an innate/trained memory should be inhibited
(autoimmune, inflammatory and cardiovascular diseases) and
those in which memory responses should be potentiated (cancer,
sepsis, immunosuppression). Recent work describes that AuNPs
could interfere with the induction of BCG-induced memory by
shifting the human memory monocytes towards a tolerant
phenotype.36 Another recent study shows that pristine graphene
can directly prime mouse macrophages towards a potentiated
secondary response to TLR-activating stimuli, by increasing the
production of inflammatory cytokines and decreasing the
production of regulatory factors.101 The effect of NPs on innate
memory is a new field with great therapeutic potential. A
representative in vitro model for assessing the capacity of NPs to
induce innate immune memory is shown in the Fig. 5.
4. Exploiting similarities and
differences: improving models and
tools for basic and translational
studies on nano-immune interactions
A number of aspects determine the outcome and the possible
risk to environmental and human health posed by exposure
Fig. 5 In vitro model for assessing the NP effect on innate memory induction in human monocytes and monocyte-derived macrophages. Cells
are primed with NPs or with stimuli that induce memory (Bacille Calmette–Guérin, BCG, that induces potentiation of subsequent responses, and
lipopolysaccharide, LPS, that induces tolerance) in the absence or presence of NPs for 24 h. Supernatants are collected, and cells rested for 6 days
until reaching again a quiescent state. On day 7, the cells are challenged with a strong inflammatory stimulus (e.g., LPS), and their innate response
measured in terms of production of inflammatory and anti-inflammatory cytokines.
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to engineered NPs, which include the inherent nature of the
particle, the level of environmental exposure, the route of the
exposure, and the susceptibility of the living species and of
the single individuals. As our studies focus on immunity, and
more specifically on innate immunity, we have examined the
interaction of NPs with the innate immune system of
different living species to assess similarities and differences.
The first general observation is that each species uses a
number of similar defensive mechanisms, adapting them to
its own specific requirements (due to environmental
conditions, range of microbial species within the
environment, lifestyle, etc.). Whether this is indeed
adaptation of common mechanisms/tools or parallel
evolution is still a matter of debate, but we see that physical/
mechanical barriers are common and very efficient
mechanisms of defence, that toll-like receptors are present in
all living species, and are used to recognition of invaders and
initiators of a defensive reaction, and that animals use
phagocytic cells in the gut as specialised innate immune
effectors. Phagocytosis and ROS production, for direct
pathogen elimination, and kinase-dependent signalling for
upregulating expression of effector proteins are also common
to many animal species. The number of known innate
immune receptors and pathways of many species are rapidly
increasing and provides a rich resource to improving our
understanding of the mechanisms of innate immunity. The
species-specific range of the relevant innate receptors is
obvious, as their number and their ligand selectivity can
differ significantly among species. The question is if the
differences are a problem or, on the contrary, they can be
considered precious tools for a deeper understanding of
human immunity and for knowledge exploitation towards
targeted immunomodulation for medical purposes. We tend
to favour the latter, based on the experience gained within a
collaborative work of comparative nano-immune interaction
assessment across living species.17 Non-human models have
a great value in unravelling the signalling pathways used in
innate immune responses, in identifying conserved
mechanisms/molecules of innate immunity, and in
evaluating the in vivo impact of exposure to NPs. For
instance, the use on invertebrate models reveals that the
large majority of NPs either do not cross the body barriers, or
are rapidly excreted, while only in some infrequent
conditions they are retained within the body. Another
important notion is that the interaction between NPs and
immune cells occurs mainly in the gut (from invertebrates to
human beings), that resident microbiota influences immune
responses, and that phagocytic cells are the main/only
immune cells involved in the first interaction with the
foreign particles. Each organism has its own array of few or
many phagocytic cell types, which may preferentially interact
with one or another foreign agent, but the basic mechanism
is common: recognition, uptake, degranulation, gene
regulation with the production of defensive molecules. As
discussed previously, each model has its own advantages and
disadvantages, specificities and commonalities, thus each
model gives us the opportunity to unravel a piece of the story.
We believe that the new frontier in our understanding of
nano-immune interactions also revolves around the
differences. Studies on resistance and tolerance to
anthropogenic challenges (including engineered NPs and
nano-/microplastics) will most likely contribute to identifying
not only some key species-specific or common protective
molecules, but also the mechanisms at the basis of the
individual innate memory profile, i.e., the pattern of
epigenetic reprogramming that defines the individual
capacity to optimally react to a challenge and that is shaped
by the previous exposure to other challenges. While in short-
lived animals this immune memory lasts for a lifetime and is
usually shared by the entire community (living in the same
environment and exposed to the same challenges), the innate
memory profiles in human beings are expected to be highly
variable and therefore warrant to a personalised approach in
the nano-risk assessment.
Which are the models and tools that we can use to assess
nano-immune interactions, which information will they
provide, and how can we use them optimally to answer to
different questions?
We have focused on protostomes, including the
earthworm Eisenia, the isopod P. scaber, the blue mussel
Mytilus, and the plant A. thaliana for in vivo studies, while
deuterostomes (including human models and the sea urchin
P. lividus) have been used directly in vitro/ex vivo, as
discussed previously.
In plants, uptake and response to NPs is dependent on
the plant species and the capacity of NPs to cross the
mechanical barriers. While in some cases NPs can induce
stress responses, it is notable that in several instances the
presence of NPs showed positive effects on growth and yield.
This opens novel opportunities in the use of NPs in
increasing the fitness of plants of agronomic interest.
Whether such effect includes an increased resistance to
pests, in terms of induction of immune memory, is currently
under investigation.
From earthworms and isopods, we learned the major
importance of gut and resident microbiota in determining
the immune response to foreign particles (including NPs). A
disturbed host-microbiota interaction, in particular in the
gut, can impact on the immune system, increasing
susceptibility to infections. NPs may have significant effects
in altering the microbiota balance, indirectly affecting the
host immune defensive competence. Thus, some protostomes
become a practical choice to study the effect of ingested NPs
on the gut microbiota interaction with the host immunity
and its ability to overcome infections, a study that cannot be
easily performed in human beings.
Mytilus shows, in response to exposure to high NP
concentrations, a stress response that is very similar to
that observed in humans, with activation of phagocytes
and release of ROS. This warrants the use of Mytilus as
easy in vivo model for evaluating the phagocyte response
to NPs.
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The comparison of the sea urchin and human genomes
allows for discriminating between conserved immune genes
and new human-specific genes. The possibility of exploiting
long-term in vitro cultures of sea urchin immune cells makes
it possible to compare in vivo effects of NPs with the
evaluation of cell-specific molecular mechanisms, and to
focus on conserved molecules across evolution. Table 1
reports the main features and mechanisms involved in the
nano-immune interaction across the selected species.
Based on the above consideration, we can state that the
realistic evaluation of nanosafety risk demands a ‘toolbox’ of
cell-based models able to reproduce with fidelity the
functions of barrier tissues and of the immune system. This
is true for both environmental and human health risk. An
important issue in this context is the accessibility of tests
and assays, which would allow their use across several
institutions, companies, agencies and private labs, without
the need of specialised instrumentation and personnel.
Within the PANDORA consortium, we have contributed to
this ‘toolbox’ through adaptation of human immune cell
models to be readily-available and user-friendly, whilst
retaining the analytical reproducibility and predictive value
obtainable only with primary cells (that retain the functions
of their tissue of origin under test conditions in culture). To
this end, human blood monocytes were extracted from blood
transfusion by-products, distributed in multiwell plates,
either used immediately after isolation or differentiated into
macrophages or dendritic cells, frozen with a novel protocol
in analysis-ready format and, in the case of poorly-adherent
cells such as dendritic cells, anchoring them on bio printable
scaffolds in NP-receptive 3D culture arrangement. Upon
thawing the different types of cells were able to react to NPs
in a fashion that is qualitatively and quantitatively
superimposable to that of cells that did not experience
freezing–thawing. The reproducibility of immune cell
response, or more often the absence of response to NP
challenge, translated to user-friendly cryopreserved cell
models offers a robust platform against which effects of
materials of uncharacterized or non-specific nano-
composition can be tested with confidence.
The next-generation in vitro human models, including co-
culture with multiple cell types, 3D spheroids, 3D tissue
sections, microfluidic organ-on-a-chip, air–liquid interface
systems, are showing great capacity in helping to bridge the
gap between in vitro and in vivo exposure/effect. Notably, 3D
organoids are self-organizing, multi-cellular aggregates that
closely resemble function and architecture of human
tissues.102 Furthermore, microfluidic technologies can model
fluidic properties in organ-like tissues, making it possible to
study small fluidic volumes in motion.103,104 Despite the
Table 1 NP interaction with innate immunity: similarities and differences across environmental organisms
Parameter
Organism
Plant Earthworm Mussel Terrestrial isopod Sea urchin Human
Exposure route Soil Soil Seawater Soil Seawater Skin, mucosal cells in
gastrointestinal and
respiratory tract
Contact level Root cells Gut and skin epithelial
cells, coelomocytes,
mucus, microbiota
Gills, gut
epithelial cells,
haemolymph,
microbiota,
haemocytes
Microbiota. No
direct contact with
gut epithelial cells
and haemocytes
Coelomic fluid,
free immune
cells, gut
epithelial cells
Gut and skin and
mucosal epithelial and
immune cells
Biocorona ND Lysenins Complement
component C1q,
haemolymph
components
ND Depends on NP
surface
characteristics
(several
proteins)
Depends on NP surface
characteristics and
route of exposure
(several proteins)
Uptake by
immune cells
Endocytosis-like Endocytosis Endocytosis No uptake Endocytosis Endocytosis
Immune-related
effects/activation
Regulatory molecules,
miRs, PRRs, MAPKs,
energy metabolism,
upregulation Rubisco
activase
PRRs, MyD88, MAPKs,
NF-κB, coelomic cytolytic
factors, lysozyme, energy
metabolism,
antimicrobial peptides
PRRs, MAPKs,
NF-κB, lysozyme,
energy
metabolism,
antimicrobial
peptides
Changes in
protein, lipid,
nucleic acid and
carbohydrate
levels. No immune
response
PRRs, MAPKs,
NFκB,
cytokines,
growth factors,
energy
metabolism
PRRs, MAPKs, NF-κB,
energy metabolism,
cytokines, chemokines,
complement system,
growth factors, etc.
Oxidative stress
and apoptosis
ROS production,
antioxidant
metabolism, Rubisco
activase, apoptotic
enzymes
ROS production,
antioxidant metabolism,
apoptotic enzymes
ROS production,
antioxidant
metabolism,
apoptotic
enzymes
ND Antioxidant
metabolism
ROS production,
antioxidant
metabolism, apoptotic
enzymes
Immune
memory
ND ND Compensatory
recall responses
to maintain
immune
homeostasis
ND ND Innate immune memory
Environmental Science: Nano Perspective
O
pe
n 
A
cc
es
s 
A
rt
ic
le
. P
ub
lis
he
d 
on
 1
4 
O
ct
ob
er
 2
02
0.
 D
ow
nl
oa
de
d 
on
 1
2/
2/
20
20
 1
0:
44
:3
4 
A
M
. 
 T
hi
s 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
C
om
m
on
s 
A
ttr
ib
ut
io
n-
N
on
C
om
m
er
ci
al
 3
.0
 U
np
or
te
d 
L
ic
en
ce
.
View Article Online
3228 | Environ. Sci.: Nano, 2020, 7, 3216–3232 This journal is © The Royal Society of Chemistry 2020
availability of outstanding organoid models representing the
lungs, gastrointestinal tract and many other organs, one of
the greatest challenges for the coming years will be to further
improve organoid-like tissues to include the interaction of
tissues/organoids with the immune cells that in real life
reside in the organ and with those that enter it during an
inflammatory reaction.
5. Inclusive and sustainable research
and innovation: the future
perspectives of research on nano-
immune interactions
In the study of nano-immune interactions, which is
specifically relating to nanosafety for both environmental
and human health, an aspect that should be duly
considered is the so-called responsible research and
innovation (RRI). RRI has gained increasing importance in
EU research policy (with its inclusion in Horizon 2020) and
academia. RRI considers scientific investigations in a larger
context by including the environmental and societal
perspective. RRI is a policy concept experiencing a dynamic
development, in which sustainability, social justice/
inclusion, open innovation, open science and open in the
world are the overarching goals. These are the backbone of
the Horizon 2020 RRI strategy and that will inform the
upcoming European Green Deal. The RRI approach
consolidates a new instrumental model (transdisciplinary,
network-governed, externally validated, problem-solving,
impact-driven).105
The RRI strategy (“Science with and for Society”) is the
approach that the PANDORA partners have tried to use to
increase the researchers' capacity to think and act towards a
more responsible, acceptable, and ethical science. The EU-
funded project PANDORA encompassed five Academic
Institutions, four Research Centres, and two small and
medium-sized enterprises (SMEs) distributed within seven
European countries (Italy, Austria, Czech Republic, Germany,
Slovenia, United Kingdom, Spain), all with proven experience
in higher education and training. Eleven PhD students have
been involved in an overarching training programme
including training-by-research, joint courses of technical,
scientific and transferrable skills, completed with an intense
inter-sectorial networking exchange plan. PANDORA merged
scientists, NP producers and experts in law and risk
management into a broader approach to environmental
nanosafety. Within this complex framework, the younger
scientists have been encouraged to critically reflect106 on the
research process within, around and outside the laboratory,
and to aim at collaboration and quality by privileging care
and sustainability in their research planning and
conduction.107 Such attitude/behaviour was particularly
suited to the goals of their studies, dealing with
environmental nanosafety, and helped them in progressing
towards the fundamental dimensions of RRI: courage, rigor,
safety, sustainability, inter- and trans-disciplinarity, critical
creativity and elegance.
6. Conclusions: what's next?
By evaluating the impact of engineered NPs on the immune
reactivity of many living organisms across evolution, from
plants to human beings, we can draw some conclusions that
can help us in choosing the direction of future research. First
is that immune responses across evolution are not too
different apart for some specialized mechanisms due to
anatomical peculiarities (e.g., plant cells that do not move).
As a consequence, reaction to NPs turned out to be pretty
similar in different species, and mainly based on immediate
elimination, no recognition, or recognition/reaction that
rapidly resolves. Only in few cases a detrimental reaction
could be observed, depending on the dose and chemical
composition of the NPs, while in other cases it was possible
to observe beneficial effects.
Based on these findings, what should we do in the future?
Abandoning nanosafety research, only because in general
NPs do not seem to be detrimental, is not a good idea
because there are too many special situations that could
increase risk. Just to make an example, the immune system
of elderly or chronically ill individuals is weakened, and
therefore we should expect that agents that are innocuous in
healthy people may cause significant damage. Another case:
even when exposure to NPs or other individual agents does
not cause a damaging effect, co-exposure to several agents at
the same time may synergize and provoke unexpected
detrimental reactions.
Thus, we may foresee that future research of nano-
immune interactions may explore these directions:
• Development and refinement of in vivo/in vitro models
that can realistically predict the nanorisk associated to acute
and chronic exposure to NPs. Goals will be having models
that discriminate between a normal immune response and a
pre-pathological reaction, models that predict risk for many
different environmental species and human beings, models
that predict realistic risk upon exposure to combined
challenges, models that predict risk in frail organisms.
• Exploiting the potential of NPs in modulating some
immune functions (such as innate memory) for designing
new immunotherapeutic or immunopreventive approaches
for human beings and crop production in agriculture.
Building on the environmental impact of nanosafety
research and its impact on society for reshaping all these
studies along the principles of RRI, contributing at the same
time in building a new generation of researchers that
privilege rigor, cooperation and sustainability.
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